CCDM Exam Questions and Answers | Exam-Dumps (Page: 4)

QUESTION: 25

Query rules were tested with test data for each logic condition within each rule.
Which of the following types of testing was conducted?

User box testing
White box testing
Black box testing
T box testing

Answer(s): C

Explanation:

Testing query rules with test data inputs to confirm expected outputs without examining the underlying program logic is an example of black box testing. According to the GCDMP (Chapter: Data Validation and System Testing), black box testing is a functional testing approach used to verify that the system performs correctly from the end-user's perspective. In this method, testers input various conditions and observe outputs to ensure the system behaves as intended -- for instance, that edit checks trigger correctly when data fall outside predefined limits.
In contrast, white box testing involves examining internal logic, code, and algorithm structures. Because data managers typically validate edit checks through data-driven test cases rather than code inspection, black box testing is the appropriate and industry-standard method. This ensures compliance with validation documentation standards as outlined in FDA 21 CFR Part 11, Section 11.10(a) and ICH E6 (R2) system validation expectations.

Reference:

(CCDM-Verified Sources)
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Database Validation and Testing, Section 4.1 Testing Approaches (Black Box and White Box) FDA 21 CFR Part 11 System Validation Requirements
ICH E6 (R2) GCP, Section 5.5.3 Computerized Systems Validation

Reveal Solution Next Question

QUESTION: 26

A study collects blood pressure.
Which is the best way to collect the data?

Coding a verbatim field with a MedDRA diagnosis
Two continuous variables
High/Low radio button
Check boxes for twenty-point increments

Answer(s): B

Explanation:

Blood pressure is a quantitative physiological measurement, typically consisting of two continuous numeric values: systolic and diastolic pressure. Therefore, the most appropriate and scientifically valid method of data collection is to use two continuous variables (e.g., systolic = 120 mmHg, diastolic = 80 mmHg).
According to the GCDMP (Chapter: CRF Design and Data Collection), data fields must be designed to capture the most precise, accurate, and analyzable form of clinical data. Numeric data should be collected using numeric data types to allow for range checks, calculations (e.g., mean arterial pressure), and statistical analysis.
Options such as categorical representations (radio buttons or check boxes) introduce rounding, data loss, and analytic limitations. Coding a verbatim diagnosis (option A) is inappropriate for numeric vital sign data and violates the principle of capturing data at the most granular level. Thus, the correct and validated method per CCDM standards is two continuous variables, ensuring accuracy, traceability, and analytical flexibility.

Reference:

(CCDM-Verified Sources)
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: CRF Design and Data Collection, Section 4.2 Best Practices for Quantitative Data Capture ICH E6 (R2) Good Clinical Practice, Section 5.5.3 Data Accuracy and Collection Standards FDA Guidance for Industry: Electronic Source Data in Clinical Investigations, Section 4.3 Data Format and Structure Requirements

Reveal Solution Next Question

QUESTION: 27

A study has an expected enrollment period of one year but has subject recruitment issues. Twelve new sites are added toward the end of the expected enrollment period to help boost enrollment.
What is the most likely impact on data flow?

The database set-up will need to be changed to allow for additional sites as they are added to the study.
The distribution of subjects selected for quality control will need to be stratified to allow for the twelve new sites.
A bolus of CRFs at the end of the study will result in the need to increase data entry and cleaning rates to meet existing timelines.
Additional sites will likely have increased query rates since site training is occurring closer to study close.

Answer(s): C

Explanation:

Adding multiple new sites late in the enrollment period creates a concentrated influx of new data near the end of the study. These sites typically start enrolling patients later, resulting in a "bolus" of Case Report Forms (CRFs) that must be entered, validated, and cleaned within a shorter timeframe to meet database lock deadlines.
According to the Good Clinical Data Management Practices (GCDMP, Chapter: Project Management and Data Flow), late site activation compresses the timeline for data management tasks, necessitating increased resources for data entry, query management, and cleaning. Data management teams must anticipate this surge and plan accordingly--either by increasing staffing or revising timelines to prevent bottlenecks and maintain quality.

While option D (increased query rates) can occur, it is a secondary effect. The most direct and consistent impact is the surge in data volume requiring expedited processing near study end.

Reference:

(CCDM-Verified Sources)
SCDM GCDMP, Chapter: Project Management, Section 5.3 Managing Changes in Site Activation and Data Flow
ICH E6(R2) GCP, Section 5.1 Quality Management and Oversight

Reveal Solution Next Question

QUESTION: 28

An international study collects lab values. Sites use different units in the source documents.
Which of the following data collection strategies will have fewer transcription errors?

Allow values to be entered as they are in the source document and derive the units based on the magnitude of the value
Allow values to be entered as they are in the source and the selection of units on the data collection form
Use a structured field and print standard units on the data collection form
Have all sites convert the values to the same unit system on the data collection form

Answer(s): B

Explanation:

In international or multicenter clinical studies, laboratory data often originate from different laboratories that use varying measurement units (e.g., mg/dL vs. mmol/L). The Good Clinical Data Management Practices (GCDMP, Chapter on CRF Design and Data Collection) provides clear guidance on managing this variability to ensure data consistency, traceability, and minimized transcription errors.
The approach that results in fewer transcription errors is to allow sites to enter lab values exactly as recorded in the source document (original lab report) and to require explicit selection of the corresponding unit from a predefined list on the data collection form or within the electronic data capture (EDC) system. This method (Option B) preserves the original source data integrity while enabling centralized or automated unit conversion later during data cleaning or statistical processing. Option B also supports compliance with ICH E6 (R2) Good Clinical Practice (GCP), which mandates that transcribed data must remain consistent with the source documents. Attempting to derive units automatically (Option A) can lead to logical errors, while forcing sites to manually convert units (Option D) introduces unnecessary complexity and increases the risk of miscalculation or inconsistent conversions. Printing only standard units on the CRF (Option C) ignores local lab practices and can lead to discrepancies between CRF entries and source records, triggering numerous data queries. The GCDMP emphasizes that CRF design must account for local variations in measurement systems and ensure that unit selection is structured (dropdowns, controlled lists) rather than free-text to prevent typographical errors and facilitate standardization during data transformation. Therefore, Option B--"Allow values to be entered as they are in the source and the selection of units on the data collection form"--is the most compliant, accurate, and efficient strategy for minimizing transcription errors in international lab data collection.

Reference:

(CCDM-Verified Sources)

Society for Clinical Data Management (SCDM), Good Clinical Data Management Practices (GCDMP), Chapter: CRF Design and Data Collection, Section 5.4 Laboratory Data Management and Unit Handling
ICH E6 (R2) Good Clinical Practice, Section 5.18 Data Handling and Record Retention CDISC SDTM Implementation Guide, Section 6.3 Handling of Laboratory Data and Standardized Units
FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6 Source Data and Accuracy of Data Entry

Reveal Solution Next Question

QUESTION: 29

What does 21 CFR Part 11 dictate in regards to a minimum expectation of EDC training prior to access?

Training must be performed
Training must include an exam
Training must be in the user's native language
Training must be face to face

Answer(s): A

Explanation:

Under FDA 21 CFR Part 11, organizations using electronic systems must ensure that all system users are trained to perform their assigned functions before gaining access to the system. The regulation requires documented evidence of training but does not specify how it should be conducted (e.g., exam-based, in person, or language-specific).
The GCDMP (Chapter: Computerized Systems and Compliance) further clarifies that personnel training should include instruction on system functionality, audit trails, data entry procedures, and electronic signatures to maintain compliance and data integrity. Training must be performed and documented but does not require a specific format or delivery method. Therefore, option A--Training must be performed--is correct, as it reflects the minimum regulatory expectation per FDA and SCDM standards.

Reference:

(CCDM-Verified Sources)
FDA 21 CFR Part 11, Section 11.10(i) Personnel Training Requirements SCDM GCDMP, Chapter: Computerized Systems and Compliance, Section 5.4 System Training and Documentation
ICH E6(R2) GCP, Section 2.8 Qualified Personnel and Training Requirements

Reveal Solution Next Question

QUESTION: 30

All of the following are preparation processes the data manager needs to take prior to database closure EXCEPT:

Checking for uncoded terms in all panels that are coded.
Ensuring all data expected for the study has been received.
Performing SAE reconciliation between the clinical and safety databases.
Ensuring study close out visits have been complete.

Answer(s): D

Explanation:

Before database lock, the Data Manager must confirm that all collected data are complete, validated, and reconciled across systems. This includes:
Ensuring data completeness (B) -- confirming all expected forms and data files have been received. Verifying coded data (A) -- ensuring no pending terms remain in coding dictionaries like MedDRA or WHO Drug.
Performing SAE reconciliation (C) -- cross-checking the clinical database against the safety system for accuracy.
However, ensuring study close-out visits (D) is not a data management function; it falls under clinical operations and monitoring responsibilities.
While data management may review confirmation of site close-outs, the activity itself is not part of pre-database lock procedures. Therefore, option D correctly identifies the exception--an activity outside the data manager's direct scope of responsibility before database closure.

Reference:

(CCDM-Verified Sources)
SCDM GCDMP, Chapter: Database Lock and Archiving, Section 5.3 Pre-Lock Validation and Reconciliation Activities
ICH E6(R2) GCP, Section 5.5.3 Data Handling and Quality Control Prior to Lock FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6.1 Database Management and Lock Procedures

Reveal Solution Next Question

QUESTION: 31

In an EDC study, user training and access must be monitored and addressed when all the following situations occur EXCEPT:

Site staff moves off of the study.
Site staff is new to the study.
A software upgrade is made that does not impact site staff or study team members.
Study team members are reassigned to a different role within the study.

Answer(s): C

Explanation:

In Electronic Data Capture (EDC) studies, proper user training and access management are essential for maintaining data integrity, security, and regulatory compliance. According to the Good Clinical

Data Management Practices (GCDMP) and FDA 21 CFR Part 11, EDC systems must ensure that only qualified and trained personnel can access study data, and that all access rights reflect current study responsibilities.
User training and access must therefore be reviewed and updated whenever:
Site staff leave the study (access revocation is required), New site staff are added (training and credentialing are required), and Study team members change roles (access levels must be modified accordingly). However, if a software upgrade occurs that does not impact the functional roles, user permissions, or data handling processes, retraining or reauthorization is not required. This is because such updates do not alter compliance-critical workflows or user interactions. Therefore, the exception is C when a software upgrade does not affect users.

Reference:

(CCDM-Verified Sources)
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Electronic Data Capture Systems, Section 7.1 User Access and Training Controls FDA 21 CFR Part 11 Electronic Records; Electronic Signatures, Section 11.10(i) & (k) ICH E6 (R2) Good Clinical Practice, Section 5.5.3 System Security and User Training

Reveal Solution Next Question

QUESTION: 32

A Clinical Data Manager reads a protocol for a clinical trial to test the efficacy of an antiviral to counteract a new epidemic. The stated primary efficacy endpoint is 3-month survival.
Which data element is needed for the primary efficacy endpoint?

Death date
Date of autopsy
Cause of death
Birth date

Answer(s): A

Explanation:

When the primary efficacy endpoint in a clinical trial is 3-month survival, the key data element required is the death date. This is because the survival endpoint is determined by calculating whether the subject lived or died within a defined time frame from study enrollment or randomization.
According to the GCDMP (Chapter: Data Management Planning and Study Start-up), the Clinical Data Manager (CDM) must identify and ensure the capture of all critical data elements necessary to evaluate the study endpoints. For time-to-event analyses (e.g., survival studies), accurate event dates (death date) are essential for endpoint derivation and statistical analysis. Other data elements such as cause of death or date of autopsy (options B and C) may support secondary analyses or safety reviews but are not necessary to determine the survival endpoint itself. Similarly, birth date (option D) contributes to demographic data but is unrelated to the primary efficacy outcome.

Reference:

(CCDM-Verified Sources)
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Management Planning and

Study Start-up, Section 4.4 Critical Data Identification for Endpoints ICH E9 Statistical Principles for Clinical Trials, Section 2.2.3 Time-to-Event Data Considerations FDA Guidance for Industry: Clinical Trial Endpoints for Drug Development

Reveal Solution Next Question

SCDM CCDM Exam (page: 4) SCDM Certified Clinical Data Manager Updated on: 09-Feb-2026

QUESTION: 25

Explanation:

Reference:

QUESTION: 26

Explanation:

Reference:

QUESTION: 27

Explanation:

Reference:

QUESTION: 28

Explanation:

Reference:

QUESTION: 29

Explanation:

Reference:

QUESTION: 30

Explanation:

Reference:

QUESTION: 31

Explanation:

Reference:

QUESTION: 32

Explanation:

Reference:

SCDM CCDM Exam (page: 4)
SCDM Certified Clinical Data Manager
Updated on: 09-Feb-2026